SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-128516
Filing Date
2024-12-13
Accepted
2024-12-13 17:16:13
Documents
17
Effectiveness Date
2024-12-13

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2430094d1_s8.htm S-8 36233
2 EXHIBIT 5.1 tm2430094d1_ex5-1.htm EX-5.1 7578
3 EXHIBIT 23.1 tm2430094d1_ex23-1.htm EX-23.1 2167
4 EXHIBIT 99.1 tm2430094d1_ex99-1.htm EX-99.1 121466
5 EX-FILING FEES tm2430094d1_ex-filingfees.htm   iXBRL EX-FILING FEES 12355
6 GRAPHIC tm2430094d1_ex5-1img001.jpg GRAPHIC 2266
  Complete submission text file 0001104659-24-128516.txt   308792

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2430094d1_ex-filingfees_htm.xml XML 4423
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-283825 | Film No.: 241549373
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)